Journal of Cancer

OncovexGALV/CD and chemotherapeutic agent Mitomycin C, show synergistic interaction on bladder TCC tumour cell lines, but not with Cisplatin or Gemcitabine. Currently the three mostly clinically used intravesical chemotherapy agents for bladder cancer are mitomycin C (MMC), cisplatin and gemcitabine. ................
................